sec filing
AB
NASDAQ · ABVC
ABVC BioPharma, Inc.
Healthcare · Biotechnology
$0.89
Down-$0.01 (-1.11%)
Updated Aug 24, 2026, 3:37 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 18.98M
- P/E ratio
- -7.4
- Dividend yield
- 0.00%
- 52-week range
- $0.82 – $3.40
- Volume
- 56.79K
- Avg. volume
- 62.85K
Price performance
ABVC price history
1M range · 20 trading sessions · Daily adjusted prices
ABVC closed at $0.89 after 20 trading sessions, down 12.75% for the selected period.
- Last close
- $0.89
- Period change
- -12.75%
- Period low
- $0.85
- Period high
- $1.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $0.92 | $0.9376 | $0.87 | $0.8899 | 56.79K |
| Aug 20, 2026 | $0.96 | $0.96 | $0.8798 | $0.8899 | 97.77K |
| Aug 19, 2026 | $0.93 | $0.95 | $0.89 | $0.9364 | 117.02K |
| Aug 18, 2026 | $0.85 | $0.8999 | $0.8208 | $0.8661 | 88.17K |
| Aug 17, 2026 | $0.8911 | $0.90 | $0.83 | $0.8499 | 127.03K |
| Aug 14, 2026 | $0.95 | $0.95 | $0.8568 | $0.8999 | 116.87K |
| Aug 13, 2026 | $0.97 | $0.9799 | $0.8933 | $0.9594 | 94.91K |
| Aug 12, 2026 | $0.8999 | $0.9999 | $0.8851 | $0.9601 | 282.22K |
| Aug 11, 2026 | $0.99 | $1.02 | $0.9034 | $0.985 | 123.04K |
| Aug 10, 2026 | $1.01 | $1.03 | $0.89 | $0.9501 | 174.96K |
| Aug 7, 2026 | $1.04 | $1.04 | $1.01 | $1.02 | 65.91K |
| Aug 6, 2026 | $1.02 | $1.029 | $1.00 | $1.02 | 36.24K |
| Aug 5, 2026 | $1.11 | $1.13 | $0.96 | $1.01 | 114.08K |
| Aug 4, 2026 | $1.04 | $1.108 | $1.0079 | $1.07 | 153.44K |
| Aug 3, 2026 | $1.04 | $1.06 | $1.00 | $1.04 | 68.11K |
| Jul 31, 2026 | $1.08 | $1.08 | $1.01 | $1.01 | 25.44K |
| Jul 30, 2026 | $1.01 | $1.08 | $0.97 | $1.08 | 118.69K |
| Jul 29, 2026 | $1.07 | $1.0795 | $0.9883 | $1.01 | 44.97K |
| Jul 28, 2026 | $1.00 | $1.09 | $0.996 | $1.06 | 59.3K |
| Jul 27, 2026 | $1.15 | $1.15 | $0.96 | $1.02 | 123.48K |
Latest ABVC news
The latest Smart Investors Daily articles mentioning ABVC.
Stock researchResearch & News · SEC Filings
Loading stock research…